Novacyt: Strong First-half Revenues Completes €3.5m in Bond Refinancing and Launches a €1.7m private placement

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, is pleased to report strong first-half sales performance across the Group, the completion of €3.5m in bond refinancing and the launch of a €1.7m private placement of new shares to support the planned growth in the second half of 2015 and into 2016.

Download press release